Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2022-08-10

SEC-registered investment adviser since 2021 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Palo Alto, CA (main office)United States United Statesabout 44
San Diego, CAUnited States United States3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.1bn reported value -9.7% vs Q1 2022
41positions
68.2%in top 10
2 new 8 added 8 reduced 3 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,434,232 $179.7m16.96% 16.96% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 8.4m, Q2 2022 8.4m
2 HILLEVAX INC COM COM 9,285,682 $101.5m9.58% 9.58% NewShares held: Q3 2021 —, Q4 2021 —, Q1 2022 0, Q2 2022 9.3m
3 KRYSTAL BIOTECH INC COM KRYS KRYS 1,095,407 $71.9m6.79% 6.79% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 866.2k, Q2 2022 1.1m +229.2k +229,157 26.4%
4 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,566,912 $69.4m6.55% 6.55% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 3.6m, Q2 2022 3.6m
5 CHINOOK THERAPEUTICS INC COM ADRO ADRO 3,595,026 $62.9m5.93% 5.93% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.7m, Q2 2022 3.6m +883.0k +882,985 32.6%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,195,403 $61.5m5.80% 5.80% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 3.2m, Q2 2022 3.2m
7 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 5,827,415 $49.2m4.64% 4.64% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 5.8m, Q2 2022 5.8m
8 SIERRA ONCOLOGY INC COM NEW COM NEW 870,636 $47.9m4.52% 4.52% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.3m, Q2 2022 870.6k -1.5m -1,471,562 -62.8%
9 IMAGO BIOSCIENCES INC COM COM 2,971,274 $39.8m3.75% 3.75% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 3.0m, Q2 2022 3.0m
10 VAXCYTE INC COM PCVX PCVX 1,787,405 $38.9m3.67% 3.67% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.3m, Q2 2022 1.8m -522.1k -522,149 -22.6%
11 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,414,823 $26.4m2.49% 2.49% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.4m, Q2 2022 1.4m
12 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,787,527 $26.1m2.46% 2.46% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.4m, Q2 2022 1.8m +370.4k +370,370 26.1%
13 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,985,757 $25.4m2.40% 2.40% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 4.2m, Q2 2022 3.0m -1.2m -1,200,000 -28.7%
14 TRICIDA INC COM TCDA TCDA 2,082,093 $20.2m1.90% 1.90% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.1m, Q2 2022 2.1m
15 COGENT BIOSCIENCES INC COM COGT COGT 2,094,154 $18.9m1.78% 1.78% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.7m, Q2 2022 2.1m -557.6k -557,600 -21.0%
16 ANAPTYSBIO INC COM ANAB ANAB 899,700 $18.3m1.72% 1.72% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 899.7k, Q2 2022 899.7k
17 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 3,111,551 $17.1m1.62% 1.62% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 3.4m, Q2 2022 3.1m -334.4k -334,422 -9.7%
18 KALVISTA PHARMACEUTICALS INC COM KALV KALV 1,572,192 $15.5m1.46% 1.46% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.6m, Q2 2022 1.6m
19 MERUS N V COM MRUS MRUS 673,979 $15.3m1.44% 1.44% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 629.0k, Q2 2022 674.0k +45.0k +45,000 7.2%
20 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,501,000 $14.8m1.40% 1.40% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.5m, Q2 2022 1.5m
21 REPLIMUNE GROUP INC COM REPL REPL 806,267 $14.1m1.33% 1.33% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 716.8k, Q2 2022 806.3k +89.5k +89,505 12.5%
22 GRITSTONE BIO INC COM GRTS GRTS 5,237,348 $12.7m1.20% 1.20% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 5.2m, Q2 2022 5.2m
23 ARVINAS INC COM ARVN ARVN 285,331 $12.0m1.13% 1.13% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 270.3k, Q2 2022 285.3k +15.0k +15,000 5.5%
24 PASSAGE BIO INC COM COM 5,009,219 $11.8m1.12% 1.12% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 5.0m, Q2 2022 5.0m
25 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 980,302 $11.3m1.07% 1.07% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.7m, Q2 2022 980.3k -759.2k -759,228 -43.6%
26 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,746,857 $10.6m1.00% 1.00% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 3.7m, Q2 2022 3.7m
27 INTELLIA THERAPEUTICS INC COM NTLA NTLA 203,684 $10.5m0.99% 0.99% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 203.7k, Q2 2022 203.7k
28 SILENCE THERAPEUTICS PLC ADS SLN SLN 881,173 $10.4m0.99% 0.99% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 881.2k, Q2 2022 881.2k
29 TYRA BIOSCIENCES INC COM TYRA TYRA 1,375,065 $9.8m0.93% 0.93% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.3m, Q2 2022 1.4m +47.4k +47,400 3.6%
30 SUTRO BIOPHARMA INC COM COM 1,776,479 $9.3m0.87% 0.87% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.8m, Q2 2022 1.8m
31 ACLARIS THERAPEUTICS INC COM ACRS ACRS 408,329 $5.7m0.54% 0.54% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 408.3k, Q2 2022 408.3k
32 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 202,260 $5.3m0.50% 0.50% AddedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 55.8k, Q2 2022 202.3k +146.4k +146,425 262.2%
33 TREVI THERAPEUTICS INC COM TRVI TRVI 1,171,627 $3.3m0.31% 0.31% NewShares held: Q3 2021 —, Q4 2021 —, Q1 2022 0, Q2 2022 1.2m
34 PARDES BIOSCIENCES INC COM COM 845,636 $2.6m0.24% 0.24% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.1m, Q2 2022 845.6k -1.2m -1,235,371 -59.4%
35 IMMUNOVANT INC COM IMVT IMVT 585,759 $2.3m0.22% 0.22% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 585.8k, Q2 2022 585.8k
36 ESSA PHARMA INC COM NEW EPI EPI 692,910 $2.2m0.21% 0.21% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 692.9k, Q2 2022 692.9k
37 IVERIC BIO INC COM OPHT OPHT 170,000 $1.6m0.15% 0.15% ReducedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 2.4m, Q2 2022 170.0k -2.3m -2,251,563 -93.0%
38 MOLECULAR TEMPLATES INC COM COM 1,374,047 $1.3m0.12% 0.12% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.4m, Q2 2022 1.4m
39 EPIZYME INC COM EPZM EPZM 739,369 $1.1m0.10% 0.10% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 739.4k, Q2 2022 739.4k
40 APTINYX INC COM COM 1,883,244 $1.1m0.10% 0.10% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 1.9m, Q2 2022 1.9m
41 NABRIVA THERAPEUTICS PLC SHS SHS 425,650 $77.0k0.01% 0.01% UnchangedShares held: Q3 2021 —, Q4 2021 —, Q1 2022 425.6k, Q2 2022 425.6k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
BICYCLE THERAPEUTICS PLC BCYC BCYC 603,521 $26.5m603.5k shares
AVADEL PHARMACEUTICALS PLC 951,814 $6.5m951.8k shares
SCHOLAR ROCK HLDG CORP SRRK SRRK 156,000 $2.0m156.0k shares